Company intelligence / Profile preview

Ariagen

Hyderabad, Telangana, Indiaaragen.com ↗
Ownership
Private
Employees
~2800
Development stage
Other
01

Overview

Aragen supports over 200 cell line development projects, with more than 100 cell lines advancing to clinical stage IND filings, and at least 4 cell lines now in products that are commercially available

Therapeutic areas
Other
Modalities
Monoclonal antibodyBispecific monoclonal antibodyAntibody fragmentRecombinant proteinFc fusion proteinEnzymeBiosimilarOther biologics (including animal biologics)Small molecule
Industry
Drug Discovery Services
02

Partnerships

Works with 7 out of top 10 global pharma companies and 100+ biotechs; exact names not disclosed

Beyond the preview

Go deeper on Ariagen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ariagen.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call